# US 2001/0036965 A1 · Iodo-nonoxynol-9-derivatives and methods for their use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0036965 A1
- Document ID: US20010036965A1
- Status: Published application
- Kind: A1
- Application number: 09/823,995
- Filed: 2001-04-03
- Published: 2001-11-01
- Earliest claimed: 1999-03-22
- Assignees: The Medical College of Hampton Roads, Eastern Virginia Medical School
- Inventors: George Digenis; Philip Fowler; Kazuya Matsumoto; Gustavo Doncel
- Web page: https://patentgrep.com/patent/US20010036965A1

## CPC

- C07B 59/001: {Acyclic or carbocyclic compounds}
- A01N 31/14: Ethers
- C07C 43/23: containing hydroxy or O-metal groups
- C07B 2200/05: Isotopically modified compounds, e.g. labelled
- Y10S 424/14: Topical contraceptives and spermacides
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

Mono- and di-iodinated nonoxynol-9-derivatives and methods for their use are disclosed.

## Claims

### Claim 1

A compound of the formula:
wherein R is a carbon atom containing moiety having at least 6 carbon atoms, Q is H or I, and n=1-25.

### Claim 2 (depends on 1)

The compound according to claim 1, wherein n=8.

### Claim 3 (depends on 1)

The compound according to claim 1, wherein n=9.

### Claim 4 (depends on 2)

The compound according to claim 2, wherein Q is H.

### Claim 5 (depends on 1)

The compound according to claim 1, wherein Q is I.

### Claim 6 (depends on 1)

The compound according to claim 1, wherein n is from 4 to 15.

### Claim 7 (depends on 6)

The compound according to claim 6, wherein n is 6-8.

### Claim 8 (depends on 7)

The compound according to claim 7, wherein n=6.

### Claim 9 (depends on 7)

The compound according to claim 7, wherein n=7.

### Claim 10 (depends on 7)

The compound according to claim 7, wherein n=8.

### Claim 11 (depends on 1)

The compound according to claim 1, wh ich is water-soluble.

### Claim 12 (depends on 1)

The compound according to claim 1, which is water insoluble.

### Claim 13 (depends on 1)

The compound according to claim 1, wherein one or both iodine atoms are radioisotopes, and the iodine radioisotopes are selected from the group consisting of 123-iodine, 125-iodine and 131-iodine.

### Claim 14 (depends on 1)

The compound according to claim 1, wherein R is nonyl or octyl.

### Claim 15

A pharmaceutical composition comprising a compound of the formula:
4
wherein R is a carbon atom containing moiety having at least 6 carbon atoms, Q is H or I, and n=1-25, and a pharmaceutically acceptable carrier.

### Claim 16 (depends on 15)

The composition according to claim 15, in a form suitable for oral administration selected from the group consisting of tablets, lozenges, granules, dragees, capsules, and pills.

### Claim 17 (depends on 15)

The composition according to claim 15, further comprising polyvinylpyrrolidone (PVP).

### Claim 18 (depends on 15)

The composition according to claim 15, in a form suitable for vaginal application.

### Claim 19 (depends on 18)

The composition according to claim 18, in a form selected from the group consisting of a sponge, cream liquid douche, gel, jelly, aerosol foam, impregnated tampon, a controlled delivery device, and a lubricant on a condom or a cap diaphragm.

### Claim 20

A method for preventing conception, the method comprising the step of:
administering an effective amount of a compound of the formula:
5
wherein R is a carbon atom containing moiety having at least 6 carbon atoms, Q is H or I, and n=1-25.

### Claim 21 (depends on 20)

The method of claim 20, comprising:
topically administering the compound to a vaginal cavity.

### Claim 22 (depends on 20)

The method of claim 20, comprising:
orally administering the compound.

### Claim 23 (depends on 20)

The method of claim 20, comprising administering the compound at a concentration between about 0.04 to about 100 mg/kg.

### Claim 24 (depends on 20)

The method of claims 20, comprising administering the compound at a concentration between about 0.01 to about 1 mg/kg.

### Claim 25

A method for reducing or preventing transmission of a sexually transmitted disease, the method comprising the step of:
administering an effective amount of a compound of the formula:
6
wherein R is a carbon atom containing moiety having at least 6 carbon atoms, Q is H or I, and n=1-25, and a pharmaceutically acceptable carrier.

### Claim 26 (depends on 25)

The method of claim 25, comprising:
topically administering the compound to a vaginal cavity.

### Claim 27 (depends on 25)

The method of claim 25, comprising:
orally administering the compound.

### Claim 28 (depends on 25)

The method of claim 25, comprising administering the compound at a concentration between about 0.04 to about 100 mg/kg.

### Claim 29 (depends on 25)

The method of claim 25, comprising administering the compound at a concentration between about 0.01 to about 1 mg/kg.

### Claim 30

A process for preparing a compound of formula:
7
wherein R is a carbon atom containing moiety having at least 6 carbon atoms, Q is H or I, and n=1-25, comprising the steps of:
reacting thallium trifluoroacetate with a compound of formula:
8
wherein Q and n are as defined above to form an electrophilic thallium intermediate, and
iodinating the intermediate.

### Claim 31 (depends on 30)

The process of claim 30, further comprising:
isolating at least one iodinated oligomer.
